Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy.

Brantly ML, Chulay JD, Wang L, Mueller C, Humphries M, Spencer LT, Rouhani F, Conlon TJ, Calcedo R, Betts MR, Spencer C, Byrne BJ, Wilson JM, Flotte TR.

Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16363-8. doi: 10.1073/pnas.0904514106. Epub 2009 Aug 12. Erratum in: Proc Natl Acad Sci U S A. 2009 Oct 13;106(41):17606.

2.

Protein detection and quantitation technologies for gel-based proteome analysis.

Weiss W, Weiland F, Görg A.

Methods Mol Biol. 2009;564:59-82. doi: 10.1007/978-1-60761-157-8_4.

PMID:
19544017
3.

International efforts for recombinant adeno-associated viral vector reference standards.

Moullier P, Snyder RO.

Mol Ther. 2008 Jul;16(7):1185-8. doi: 10.1038/mt.2008.125. No abstract available.

4.

Safety and efficacy of gene transfer for Leber's congenital amaurosis.

Maguire AM, Simonelli F, Pierce EA, Pugh EN Jr, Mingozzi F, Bennicelli J, Banfi S, Marshall KA, Testa F, Surace EM, Rossi S, Lyubarsky A, Arruda VR, Konkle B, Stone E, Sun J, Jacobs J, Dell'Osso L, Hertle R, Ma JX, Redmond TM, Zhu X, Hauck B, Zelenaia O, Shindler KS, Maguire MG, Wright JF, Volpe NJ, McDonnell JW, Auricchio A, High KA, Bennett J.

N Engl J Med. 2008 May 22;358(21):2240-8. doi: 10.1056/NEJMoa0802315. Epub 2008 Apr 27.

5.

Clinical gene therapy using recombinant adeno-associated virus vectors.

Mueller C, Flotte TR.

Gene Ther. 2008 Jun;15(11):858-63. doi: 10.1038/gt.2008.68. Epub 2008 Apr 17. Review.

PMID:
18418415
6.

Proteolytic mapping of the adeno-associated virus capsid.

Van Vliet K, Blouin V, Agbandje-McKenna M, Snyder RO.

Mol Ther. 2006 Dec;14(6):809-21. Epub 2006 Sep 27.

7.

Treatment of human disease by adeno-associated viral gene transfer.

Warrington KH Jr, Herzog RW.

Hum Genet. 2006 Jul;119(6):571-603. Epub 2006 Apr 13. Review.

PMID:
16612615
8.

Infectious titer assay for adeno-associated virus vectors with sensitivity sufficient to detect single infectious events.

Zen Z, Espinoza Y, Bleu T, Sommer JM, Wright JF.

Hum Gene Ther. 2004 Jul;15(7):709-15.

PMID:
15298029
9.
10.

Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial.

Moss RB, Rodman D, Spencer LT, Aitken ML, Zeitlin PL, Waltz D, Milla C, Brody AS, Clancy JP, Ramsey B, Hamblett N, Heald AE.

Chest. 2004 Feb;125(2):509-21.

PMID:
14769732
11.

Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo.

McCarty DM, Fu H, Monahan PE, Toulson CE, Naik P, Samulski RJ.

Gene Ther. 2003 Dec;10(26):2112-8.

PMID:
14625565
12.

Recombinant adeno-associated virus: formulation challenges and strategies for a gene therapy vector.

Wright JF, Qu G, Tang C, Sommer JM.

Curr Opin Drug Discov Devel. 2003 Mar;6(2):174-8. Review.

PMID:
12669452
13.

Quantification of adeno-associated virus particles and empty capsids by optical density measurement.

Sommer JM, Smith PH, Parthasarathy S, Isaacs J, Vijay S, Kieran J, Powell SK, McClelland A, Wright JF.

Mol Ther. 2003 Jan;7(1):122-8.

14.

Production of clinical-grade recombinant adeno-associated virus vectors.

Snyder RO, Flotte TR.

Curr Opin Biotechnol. 2002 Oct;13(5):418-23. Review.

PMID:
12459331
15.

A comparison between Sypro Ruby and ruthenium II tris (bathophenanthroline disulfonate) as fluorescent stains for protein detection in gels.

Rabilloud T, Strub JM, Luche S, van Dorsselaer A, Lunardi J.

Proteomics. 2001 May;1(5):699-704.

PMID:
11678039
16.
17.

Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome.

Chadeuf G, Favre D, Tessier J, Provost N, Nony P, Kleinschmidt J, Moullier P, Salvetti A.

J Gene Med. 2000 Jul-Aug;2(4):260-8.

PMID:
10953917
18.

Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield.

Zolotukhin S, Byrne BJ, Mason E, Zolotukhin I, Potter M, Chesnut K, Summerford C, Samulski RJ, Muzyczka N.

Gene Ther. 1999 Jun;6(6):973-85.

19.

Novel tools for production and purification of recombinant adenoassociated virus vectors.

Grimm D, Kern A, Rittner K, Kleinschmidt JA.

Hum Gene Ther. 1998 Dec 10;9(18):2745-60.

PMID:
9874273
20.

Factors influencing recombinant adeno-associated virus production.

Salvetti A, Orève S, Chadeuf G, Favre D, Cherel Y, Champion-Arnaud P, David-Ameline J, Moullier P.

Hum Gene Ther. 1998 Mar 20;9(5):695-706.

PMID:
9551617

Supplemental Content

Support Center